ArticleBJPsych open2026
Childhood ADHD and autism spectrum disorder difficulties: exploring the impact of copy number variants on young adult outcomes.
Article in BJPsych open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rare copy number variants (CNVs; deleted/duplicated DNA segments) are associated with childhood attention-deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). It is unknown whether carrying a CNV moderates the effect of ADHD/ASD on adult outcomes. In a UK population-based cohort, the Avon Longitudinal Study of Parents and Children, ADHD and ASD difficulties at ages 7-16 years were defined categorically. Outcomes included: General Certificate of Secondary Education non-attainment; depression at ages 18 and 24; functioning at age 25; not in education, employment or training; and receiving state benefits at age 25. Logistic regressions were used to assess associations between ADHD/ASD and outcomes, and to test CNVs as moderators. Multiple imputation was used to account for data missingness. We did not find strong evidence of CNVs moderating the effect of ADHD or ASD on young adult outcomes. However, confidence intervals for the moderating effect were wide, so further research in larger clinical samples is necessary.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.